Stay updated on Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.

Latest updates to the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page
- Check6 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check14 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check50 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check78 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.